Sorrento Therapeutics Gets FDA Clearance for RTX Phase 2 Trial,

By Michael Dabaie. Sorrento Therapeutics Inc. said it received Food and Drug Administration clearance to proceed with a Phase 2 clinical study of …, By Michael Dabaie. Sorrento Therapeutics Inc. said it received Food and Drug Administration clearance to proceed with a Phase 2 clinical study of …, Read More

Scroll to Top